Companies seeking marketing approval for drugs in Canada are being asked by the regulator to start submitting information to verify whether disaggregated data for sex, age and race is present in their clinical evidence.
Canada Addresses Diversity In Clinical Trials With New Rule For Drug Filings
Health Canada wants drug sponsors to start answering questions relating to disaggregated data for sex, age and race.
